Barrington Research Forecasts CCRN FY2024 Earnings

Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Equities researchers at Barrington Research issued their FY2024 EPS estimates for shares of Cross Country Healthcare in a research note issued on Tuesday, December 10th. Barrington Research analyst K. Steinke forecasts that the business services provider will post earnings of $0.54 per share for the year. Barrington Research has a “Market Perform” rating on the stock. The consensus estimate for Cross Country Healthcare’s current full-year earnings is $0.53 per share. Barrington Research also issued estimates for Cross Country Healthcare’s Q4 2024 earnings at $0.12 EPS and FY2025 earnings at $0.55 EPS.

A number of other analysts have also recently weighed in on the company. William Blair cut Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Truist Financial boosted their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the stock a “hold” rating in a research note on Thursday, December 5th. Finally, Benchmark lowered shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Four research analysts have rated the stock with a hold rating, According to MarketBeat.com, Cross Country Healthcare currently has a consensus rating of “Hold” and an average price target of $18.54.

Cross Country Healthcare Stock Performance

Cross Country Healthcare stock opened at $18.06 on Thursday. The company has a fifty day simple moving average of $12.48 and a 200-day simple moving average of $13.84. The stock has a market cap of $594.54 million, a P/E ratio of -361.13, a price-to-earnings-growth ratio of 3.39 and a beta of 0.61. Cross Country Healthcare has a 12-month low of $9.58 and a 12-month high of $23.64.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CCRN. Truvestments Capital LLC acquired a new stake in shares of Cross Country Healthcare during the third quarter worth about $39,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Cross Country Healthcare in the third quarter valued at approximately $49,000. nVerses Capital LLC acquired a new position in Cross Country Healthcare during the second quarter worth $50,000. Point72 DIFC Ltd purchased a new stake in shares of Cross Country Healthcare during the 3rd quarter worth $52,000. Finally, Gladius Capital Management LP grew its stake in shares of Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock worth $54,000 after purchasing an additional 1,812 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.